Mathias Tesson
Impact in
-
- Pancreatic and Hepatic Oncology Research
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
-
- Breast Cancer Treatment Studies
Papers in
-
- Radiopharmaceutical Chemistry and Applications 6
- Effects of Radiation Exposure 2
- Oncology 6
- Pancreatic and Hepatic Oncology Research 3
- Cancer-related Molecular Pathways 1
- Co-authors
- Robert J. Mairs (9 shared papers)Colin J. Rae (6 shared papers)John W. Babich (6 shared papers)Marie Boyd (4 shared papers)Annette Sørensen (1 shared paper)Colin Nixon (3 shared papers)Giorgio Anselmi (1 shared paper)Mark N. Gaze (3 shared papers)
- Journals
- Journal of Nuclear Medicine (3 papers)Disease Models & Mechanisms (2 papers)Oncotarget (2 papers)Journal of Pharmacy and Pharmacology (1 paper)Gastroenterology (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mathias Tesson
14 papers receiving 322 citations
Peers
Comparison fields: 5 of 37
- Oncology 142
- Cancer Research 41
- Radiology, Nuclear Medicine and Imaging 48
- Toxicology 11
- Neurology 20
Countries citing papers authored by Mathias Tesson
This map shows the geographic impact of Mathias Tesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Tesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Tesson more than expected).
Fields of papers citing papers by Mathias Tesson
This network shows the impact of papers produced by Mathias Tesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Tesson. The network helps show where Mathias Tesson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathias Tesson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 114 | |
| 2 | 2013 | 73 | |
| 3 | 2016 | 25 | |
| 4 | 2016 | 24 | |
| 5 | 2012 | 21 | |
| 6 | 2017 | 21 | |
| 7 | 2018 | 14 | |
| 8 | 2025 | 12 | |
| 9 | 2013 | 8 | |
| 10 | 2015 | 7 | |
| 11 | 2024 | 4 | |
| 12 | 2014 | 3 | |
| 13 | 2017 | 2 | |
| 14 | 2024 | 2 | |
| 15 | Enhancement of prostate-targeted radiotherapy using [131I]MIP-1095 in combination with radiosensitizing chemotherapeutic drugs | 2013 | 0 |
About Mathias Tesson
Mathias Tesson is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Cancer Research, Neurology and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 330 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (6 papers), Pancreatic and Hepatic Oncology Research (3 papers), Radiation Therapy and Dosimetry (3 papers), Effects of Radiation Exposure (2 papers), Neuroblastoma Research and Treatments (2 papers), Immune cells in cancer (1 paper), Cancer-related Molecular Pathways (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Oncology (142 citations), Cancer Research (41 citations), Radiology, Nuclear Medicine and Imaging (48 citations), Toxicology (11 citations) and Neurology (20 citations). Mathias Tesson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Robert J. Mairs, Colin J. Rae, John W. Babich, Marie Boyd, Annette Sørensen, Colin Nixon, Giorgio Anselmi, Mark N. Gaze, Joanne Edwards and Zahra M. A. Mohammed. Their work appears in journals such as Journal of Nuclear Medicine, Disease Models & Mechanisms, Oncotarget, Journal of Pharmacy and Pharmacology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.